Cathie Wood's ARK Invest Sells Over 690,000 Shares of Takeda Pharma

Investing

Published: November 17, 2021 7:55 am

One ARK Invest exchange-traded fund run by ETF star Cathie Wood sold over 690,000 shares of Takeda Pharmaceutical Co. Ltd. (NYSE: TAK) on Tuesday, as the share price of this fund traded was up 2% in the day’s session. Its share price has greatly improved over the past year.
[in-text-ad]
ARK Genomic Revolution ETF (NYSEARCA: ARKG) sold 692,660 shares of Takeda. At Tuesday’s closing price, this would have valued this sale at roughly $9.8 million. This is only a small fraction of the total holdings. This fund is flat over the past 52 weeks.

Here is a quick look at all the other sales that took place across all ARK ETFs:

Fund	Ticker	Name	Shares
ARKF	OPEN	OPENDOOR TECHNOLOGIES	166,353
ARKF	Z	ZILLOW	123,790
ARKG	INCY	INCYTE	6,219
ARKG	TAK	TAKEDA PHARMACEUTICAL	692,660
ARKG	VEEV	VEEVA SYSTEMS	31,755
ARKQ	LMT	LOCKHEED MARTIN	4,885
ARKQ	U	UNITY SOFTWARE	11,000
ARKW	U	UNITY SOFTWARE	112,381
ARKX	HOFP	THALES	15,040

Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St., owner of a673b.bigscoots-temp.com.

ALSO READ: Holiday Shopping Has Exploded Early: 4 Large-Cap Retail Winners to Buy Now

Are You Ahead, or Behind on Retirement? (sponsor)

If you’re one of the over 4 Million Americans set to retire this year, you may want to pay attention.

Finding a financial advisor who puts your interest first can be the difference between a rich retirement and barely getting by, and today it’s easier than ever. SmartAsset’s free tool matches you with up to three fiduciary financial advisors that serve your area in minutes. Each advisor has been carefully vetted, and must act in your best interests. Start your search now.

Don’t waste another minute; get started right here and help your retirement dreams become a retirement reality.